-
1Academic Journal
المؤلفون: A. D. Zikiryakhodzhaev, I. M. Shirokikh, N. V. Kharchenko, G. M. Zapirov, E. K. Saribekyan, N. V. Ablitsova, A. V. Ermakov, M. A. Kunda, V. S. Sidorenko, H. S. Gevorgyan, А. Д. Зикиряходжаев, И. М. Широких, Н. В. Харченко, Г. М. Запиров, Э. К. Сарибекян, Н. В. Аблицова, А. В. Ермаков, М. А. Кунда, В. С. Сидоренко, Г. С. Геворгян
المصدر: Research and Practical Medicine Journal; Том 4, № 2 (2017); 13-22 ; Research'n Practical Medicine Journal; Том 4, № 2 (2017); 13-22 ; 2410-1893 ; 10.17709/2409-2231-2017-4-2
مصطلحات موضوعية: фиброэпителиальные опухоли молочных желез, leaf-shaped tumor, mammary gland, fibroepithelial tumors of the mammary glands, листовидная опухоль, молочная железа
وصف الملف: application/pdf
Relation: https://www.rpmj.ru/rpmj/article/view/182/178; Atalay C, Kinas V, Celebioglu S. Analysis of patients with phylloides tumor of the breast. Turkish J Surg. 2014; 30 (3): 129–132. DOI:10.5152/UCD.2014.2719; Волченко А. А., Пак Д. Д., Усов Ф. Н., Фетисова Е. Ю., Ефанов В. В. Гигантская листовидная опухоль молочной железы. Онкохирургия. 2012; 4 (2): 77–80.; Müller J. Über den feineren Ban und die Formen der Krankaften Geschwulste. Berlin: G Reiner. 1838; 1: 54–57.; World Health Organization Histological typing of breast tumors. Tumori. 1982; 68: 181–198.; Liang М, Ramaswamy В, Patterson С, McKelvey MT, Gordillo G, Nuovo GJ, et al. Giant breast tumors: Surgical management of phyllodes tumors, potential for reconstructive surgery and a review of literature. World J Surg Oncol. 2008; 6: 117. DOI:10.1186/1477–7819–6-117; Tavassoli FA, Devilee P.Pathology and genetics of tumours of the breast and female genital organs. In: World Health Organization Classification of Tumours, IARC Press, Lyons 2003. p. 99.; Bernstein L, Deapen D, Ross RK. The descriptive epidemiology of malignant cystosarcoma phyllodes tumors of the breast. Cancer. 1993; 71 (10): 3020–3024. DOI:10.1002/1097–0142 (19930515)71:103.0.CO;2-G; Barrio AV, Clark BD, Goldberg JI, Hoque LW, Bernik SF, Flynn LW, et al. Clinicopathologic features and long-term outcom es of 2 93phyllodes tum ors of the breast. Ann Surg Oncol 2007; 14 (10): 2961–2970. DOI:10.1245/s10434–007–9439-z; Calhoun K, Lawton TJ, Kim JM, et al. Phyllodes tumors. In: Diseases of the breast. Harris J, Lippman ME, Osborne CK, Morrow M (eds). Lippincott Williams and Wilkins, 2010, p.781.; Telli ML, Horst KC, Guardino AE, Dirbas FM, Carlson RW. Phyllodes tumors of the breast: natural history, diagnosis, and treatment. J Natl Compr Canc Netw. 2007 Mar; 5 (3): 324–330. DOI:10.6004/jnccn.2007.0027; Carter BA, Page DL. Phyllodes tumor of the breast: local recurrence versus metastatic capacity. Hum Pathol. 2004; 35 (9): 1051–1052. DOI:10.1016/j.humpath.2004.08.001; Reinfuss M, Mituś J, Duda K, Stelmach A, Ryś J, Smolak K. The treatment and prognosis of patients with phyllodes tumor of the breast: an analysis of 170 cases. Cancer. 1996; 77 (5): 910–916. DOI:10.1002/(SICI)1097–0142 (19960301)77:53.0.CO;2–6; National Comprehensive Cancer Network (NCCN). NCCN Clinical practice guidelines in oncology. Availavle at: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp (Accessed on February 27, 2016); Jacklin RK, Ridgway PF, Ziprin P, Healy V, Hadjiminas D, Darzi A. Optimising preoperative diagnosis in phyllodes tumour of the breast. J Clin Pathol. 2006; 59 (5): 454–459. DOI:10.1136/jcp.2005.025866; Jang JH, Choi MY, Lee SK, Kim S, Kim J, Lee J, et al. Clinicopathologic risk factors for the local recurrence of phyllodes tumors of the breast. Ann Surg Oncol. 2012 Aug; 19 (8): 2612–7. DOI:10.1245/s10434–012–2307–5; Tavassoli FA, Devilee P.Genetics of tumours of the breast and female genital organs. In: World Health Organization Classification of Tumours, IARC Press, Lyons 2003. p. 99.; Kuijper A, Buerger H, Simon R, Schaefer KL, Croonen A, Boecker W, et al. Analysis of the progression of fibroepithelial tumours of the breast by PCR-based clonality assay. J Pathol. 2002; 197 (5): 575–581. DOI:10.1002/path.1161; Wiratkapun C, Piyapan P, Lertsithichai P, Larbcharoensub N. Fibroadenoma versus phyllodes tumor: distinguishing factors in patients diagnosed with fibroepithelial lesions after a core needle biopsy. Diagn Interv Radiol. 2014 Jan-Feb; 20 (1): 27–33. DOI:10.5152/dir.2013.13133; Летягин В. П., Ермилова В. Д., Воротников И. К. Злокачественные неэпиелиальные опухоли молочных желез. Вестник РОНЦ им. Н. Н. Блохина РАМН. 1996; 7 (3): 57–59; Волченко А. А., Пак Д. Д., Усов Ф. Н., Фетисова Е. Ю. Гигантская листовидная опухоль молочной железы: клиническое наблюдение. Опухоли женской репродуктивной системы. 2012; 2: 27–29.; Spitaleri G, Toesca A, Botteri E, Bottiglieri L, Rotmensz N, Boselli S, et al. Breast phyllodes tumor: a review of literature and a single center retrospective series analysis. Crit Rev Oncol Hematol. 2013 Nov; 88 (2): 427–36. DOI:10.1016/j.critrevonc.2013.06.005; Chaney AW, Pollack A, McNeese MD, Zagars GK, Pisters PW, Pollock RE, et al. Primary treatment of cystosarcoma phyllodes of the breast. Cancer 2000; 89 (7): 1502–1511.; Ward RM, Evans HL. Cystosarcoma phyllodes: a clinicopathologic study of 26 cases. Cancer. 1986; 58 (10): 2282–2289. DOI:10.1002/1097–0142 (19861115)58:103.0.CO;2–2; Cohn-Cedermark G, Rutqvist LE, Rosendahl I, Silfverswärd C. Prognostic factors in cystosarcoma phyllodes. A clinicopathologic study of 77 patients. Cancer. 1991; 68 (9): 2017–2022. DOI:10.1002/1097–0142 (19911101)68:93.0.CO;2-V; Norris HJ, Taylor HB. Relationship of histologic features to behavior of cystosarcoma phyllodes. Analysis of ninety-four cases. Cancer. 1967; 20 (12): 2090–2099. DOI:10.1002/1097–0142 (196712)20:123.0.CO;2-L; Hawkins RE, Schofield JB, Fisher C, Fisher C, Wiltshaw E, McKinna JA. The clinical and histologic criteria that predict m etastases from cystosarcom a phyllodes. Cancer 1992; 69 (1): 141–147. DOI:10.1002/1097–0142 (19920101)69:13.0.CO;2–1; Fajdić J, Gotovac N, Hrgović Z, Kristek J, Horvat V, Kaufmann M. Phyllodes tumors of the breast diagnostic and therapeutic dilemmas. Onkologie. 2007 Mar; 30 (3): 113–118. DOI:10.1159/000099580; Macdonald OK, Lee CM, Tward JD, Chappel CD, Gaffney DK. Malignant phyllodes tumor of the female breast: association of primary therapy with cause-specific survival from the Surveillance, Epidemiology, and End Results (SEER) program. Cancer 2006; 107 (9): 2127–2133. DOI:10.1002/cncr.22228; Barth RJ Jr, Wells WA, Mitchell SE, Cole BF. A prospective, multi-institutional study of adjuvant radiotherapy after resection of malignant phyllodes tumors. Ann Surg Oncol. 2009 Aug; 16 (8): 2288–2294. DOI:10.1245/s10434–009–0489–2; Kapiris I, Nasiri N, A’Hern R, Healy V, Gui GP. Outcome and predictive factors of local recurrence and distant m etastases following prim ary surgical treatm ent of highgrade malignant phyllodes tumours of the breast. Eur J Surg Oncol. 2001; 27 (8): 723–730. DOI:10.1053/ejso.2001.1207; Parker SJ, Harries SA. Phyllodes tumours. Postgrad Med J. 2001 Jul; 77 (909): 428–435. DOI:10.1136/pmj.77.909.428; Belkacémi Y, Bousquet G, Marsiglia H, Ray-Coquard I, Magné N, Malard Y, et al. Phyllodes tumor of the breast. Int J Radiat Oncol Biol Phys 2008; 70 (2): 492–500. DOI:10.1016/j.ijrobp.2007.06.059; Pezner RD, Schultheiss TE, Paz IB. Malignant phyllodes tumor of the breast: local control rates with surgery alone. Int J Radiat Oncol Biol Phys. 2008 Jul 1; 71 (3): 710–713. DOI:10.1016/j.ijrobp.2007.10.051; Gnerlich JL, Williams RT, Yao K, Jaskowiak N, Kulkarni SA. Utilization of radiotherapy for malignant phyllodes tumors: analysis of the National Cancer Data Base, 1998–2009. Ann Surg Oncol. 2014 Apr; 21 (4): 1222–30. DOI:10.1245/s10434–013–3395–6; Morales-Vásquez F, Gonzalez-Angulo AM, Broglio K, Lopez-Basave HN, Gallardo D, Hortobagyi GN, et al. Adjuvant chemotherapy with doxorubicin and dacarbazine has no effect in recurrence-free surviv al of m alignant phyllodes tumors of the breast. Breast J. 2007 Nov-Dec; 13 (6): 551–556. DOI:10.1111/j.1524–4741.2007.00510.x; Burton GV, Hart LL, Leight GS Jr, Iglehart JD, McCarty KS Jr, Cox EB. Cystosarcoma phyllodes. Effective therapy with cisplatin and etoposide chemotherapy. Cancer. 1989; 63 (11): 2088–2092. DOI:10.1002/1097–0142 (19890601)63:113.0.CO;2-C; Sapino A, Bosco M, Cassoni P, Castellano I, Arisio R, Cserni G, et al. Estrogen receptor-beta is expressed in stromal cells of fibroadenoma and phyllodes tumors of the breast. Mod Pathol 2006; 19 (4): 599–606. DOI:10.1038/modpathol.3800574; Tse GM, Lee CS, Kung FY, Scolyer RA, Law BK, Lau TS, et al. Hormonal receptors expression in epithelial cells of mammary phyllodes tumors correlates with pathologic grade of the tumor: a multicenter study of 143 cases. Am J Clin Pathol. 2002; 118 (4): 522–526. DOI:10.1309/D206-DLF8-WDNC–XJ8K; Confavreux C, Lurkin A, Mitton N, Blondet R, Saba C, Ranchère D, et al. Sarcomas and malignant phyllodes tumours of the breast — a retrospective study. Eur J Cancer. 2006 Nov; 42 (16): 2715–2721. DOI:10.1016/j.ejca.2006.05.040; https://www.rpmj.ru/rpmj/article/view/182